Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II double-blind randomized trial of oral recombinant oxalate decarboxylase powder in enteric hyperoxaluria
CTR20263231Phase 2Active
- Sponsor
- Comfort Biopharma
- Start
- Aug 2026
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of recombinant oxalate decarboxylase in absorptive hyperoxaluria, sponsored by Comfort Biopharma. Started Aug 2026; status: active.
02
Drugs
recombinant oxalate decarboxylase
03
Conditions
absorptive hyperoxaluria
Beyond the preview
Go deeper on CTR20263231.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20263231.